| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.28 | 5e-15 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.27 | 2e-13 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.47 | 4e-11 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.23 | 6e-11 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-09 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-08 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.27 | 1e-07 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-07 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.3 | 3e-07 |